Under the agreement, the companies will launch a joint pilot led by their respective R&D teams. On the Tikun Olam-Cannbit side, the pilot will be led by the distinguished Dr.
The Netanya-based company manufactures a broad array of nutritional supplements and therapeutic herbs in their factory located at the HarYona industrial park in Nazareth Illit and specializes in developing and manufacturing soft gel capsules.
“We are going to start hopefully in Israel if the regulation will allow it, but we are not going to wait only for the Israel regulatory approval.
It’s going to contain compounds from mushrooms and compounds from cannabis and to sell it in European countries where it’s considered a food supplement,” says Haim.
While the use of cannabis in food and beverages for recreational purposes has always been popular — even more so now that it’s legalized — the emergence of cannabis in the food market goes beyond recreational purposes to offer health and nutritional value.
“There is a lot of good quality cannabinoids that are not psychoactives that we discovered and researched over the years,” says Haim.
The mushroom market, originating in the Far East, has also reached the US and Europe in recent years.
We are delighted that Ambrosia SupHerb has decided to invest in the company and thank them for their trust in our vision and their decision to make this strategic investment,” says Avinoam Sapir, general manager at Tikkun Olam-Cannbit.
“The ultimate goal is to give people nutrients they might not be getting otherwise,” says Haim.